We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+2.68%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$37.9B
AUM Growth
-$464M
Cap. Flow
-$1.14B
Cap. Flow %
-3.01%
Top 10 Hldgs %
41.6%
Holding
747
New
101
Increased
198
Reduced
342
Closed
84

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$145M
2
IBM icon
IBM
IBM
+$127M
3
QCOM icon
Qualcomm
QCOM
+$103M
4
RTX icon
RTX Corp
RTX
+$73.1M
5
UNH icon
UnitedHealth
UNH
+$70.4M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$295M
2
HPQ icon
HP
HPQ
+$248M
3
CSCO icon
Cisco
CSCO
+$204M
4
JNJ icon
Johnson & Johnson
JNJ
+$176M
5
TGT icon
Target
TGT
+$165M

Sector Composition

Rank Sector Weight
1 Healthcare 24.59%
2 Consumer Staples 23.17%
3 Technology 21.44%
4 Communication Services 7.02%
5 Energy 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$127B
$387M 1.02%
8,368,932
+790,999
+10% +$34.7M
LLY icon
27
Eli Lilly
LLY
$1.07T
$353M 0.93%
7,012,820
+758,468
+12% +$39.7M
TGT icon
28
Target
TGT
$62.1B
$351M 0.92%
5,479,685
-2,421,800
-31% -$165M
NKE icon
29
Nike
NKE
$61.9B
$304M 0.8%
8,366,212
-606,054
-7% -$19.8M
AMGN icon
30
Amgen
AMGN
$203B
$299M 0.79%
2,668,851
+602,464
+29% +$65.3M
EEM icon
31
iShares MSCI Emerging Markets ETF
EEM
$28B
$264M 0.7%
6,477,052
-529,306
-8% -$21M
VALE icon
32
Vale
VALE
$62.9B
$209M 0.55%
13,363,171
-382,180
-3% -$5.66M
ZBH icon
33
Zimmer Biomet
ZBH
$17.7B
$209M 0.55%
2,615,416
-778,527
-23% -$61.3M
MA icon
34
Mastercard
MA
$477B
$207M 0.54%
3,069,690
-1,846,800
-38% -$116M
VALE.P
35
DELISTED
Vale S A
VALE.P
$199M 0.52%
13,989,458
-601,165
-4% -$7.95M
WBA
36
DELISTED
Walgreens Boots Alliance
WBA
$196M 0.52%
3,640,147
+800,061
+28% +$40.2M
LO
37
DELISTED
LORILLARD INC COM STK
LO
$193M 0.51%
4,306,660
-2,807,923
-39% -$124M
GILD icon
38
Gilead Sciences
GILD
$161B
$184M 0.48%
2,922,399
+391,794
+15% +$23.4M
COST icon
39
Costco
COST
$415B
$180M 0.47%
1,561,362
+236,204
+18% +$27.3M
EMC
40
DELISTED
EMC CORPORATION
EMC
$180M 0.47%
7,031,876
+1,208,776
+21% +$31.4M
BAX icon
41
Baxter International
BAX
$11.6B
$178M 0.47%
4,987,744
+1,062,321
+27% +$41.2M
BIDU icon
42
Baidu
BIDU
$35.8B
$178M 0.47%
1,145,350
+1,123,350
+5,106% +$145M
KMB icon
43
Kimberly-Clark
KMB
$36.4B
$174M 0.46%
1,928,779
+291,000
+18% +$27M
CPA icon
44
Copa Holdings
CPA
$5.56B
$173M 0.46%
1,248,136
+67,694
+6% +$9.28M
SYY icon
45
Sysco
SYY
$39.7B
$168M 0.44%
5,290,059
+128,293
+2% +$4.3M
V icon
46
Visa
V
$677B
$168M 0.44%
3,511,868
-2,049,112
-37% -$94.7M
CVS icon
47
CVS Health
CVS
$137B
$165M 0.43%
2,902,828
+595,854
+26% +$35.5M
BDX icon
48
Becton Dickinson
BDX
$43.1B
$159M 0.42%
1,632,153
+309,867
+23% +$30.3M
SYK icon
49
Stryker
SYK
$127B
$155M 0.41%
2,296,002
+681,638
+42% +$47.1M
AMX icon
50
America Movil
AMX
$78.1B
$154M 0.41%
7,781,940
-986,620
-11% -$20.3M
1
2
3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2013 Portfolio in Review

As of Q3 2013, Grantham, Mayo, Van Otterloo & Co (GMO) held 747 positions worth $37.9B, down 1.2% from $38.4B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $1.14B in Q3 2013, closing 84 positions and reducing 342 holdings. Its most notable exit was SPRINT CORP FON COM, an estimated $36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Omnicom Group worth $35.3M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2013 buy was Omnicom Group: 557,023 shares worth $35.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Baidu in Q3 2013, an estimated $145M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2013 reduction was Pfizer, cutting an estimated $295M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $36M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 42% of its $37.9B portfolio in Q3 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 101 new positions and closed 84 in Q3 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 1.2% quarter-over-quarter to $37.9B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2013, filed 14 Nov 2013.